Vera-Aviles Mayra, Moreno-Fernandez Jorge, Kose Tugba, Hider Robert, Latunde-Dada Gladys O
Department of Nutritional Sciences, School of Life Course and Population Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.
Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.
Amino Acids. 2025 May 12;57(1):26. doi: 10.1007/s00726-025-03451-8.
Histidine and carnosine can form complexes with divalent metal ions such as Fe, potentially providing stability to intracellular labile iron. Anaemia is a common comorbidity in the late stages of kidney disease, and patients are treated with erythropoiesis-stimulating agents (ESAs) and iron supplementation. However, iron supplementation is also associated with worse long-term outcomes. The purpose of this study is to investigate how histidine and carnosine supplementation can reduce symptoms of anaemia of chronic kidney disease (CKD) and the effects associated with iron-overloaded conditions. Adenine-induced chronic kidney disease mice were treated with histidine and carnosine by oral gavage for 10 days. Additionally, a model involving iron overload in mice was established, and these mice received concurrent treatment with histidine and carnosine. Haemoglobin, non-haem iron, malondialdehyde (MDA) and iron parameters were measured. Carnosine increased erythropoietin (EPO) levels (35.62 µg/ml ± 11.43) and resulted in haemoglobin repletion (16.7 g/dL ± 3.4). When iron was supplemented alongside with histidine or carnosine, there were better effects on haemoglobin repletion (14.22 ± 1.7 and 13.82 ± 2.15 g/ dL respectively), ferritin (59.5 ± 16.4, 52 ± 29.5 µg/ml) and non-haem iron (0.8 ± 0.21, 0.7 ± 0.38 nmol/mg), than the group receiving iron alone (p < 0.05). Furthermore, histidine and carnosine reduced non-haem iron and MDA, in iron-loaded conditions (p < 0.05). These positive effects observed in histidine and carnosine could be associated with reactive oxygen species (ROS) scavenging. EPO restoring levels in CKD model and the increment in haemoglobin and ferritin in carnosine treatments suggested the potential formation of a ternary complex with iron-glutathione. In conclusion, our results indicate the beneficial effect of histidine and carnosine in the context of iron supplementation for the correction of haemoglobin and protection against iron-loaded conditions.
组氨酸和肌肽可与二价金属离子(如铁)形成复合物,这可能为细胞内不稳定铁提供稳定性。贫血是肾病晚期常见的合并症,患者接受促红细胞生成素(ESA)和铁补充剂治疗。然而,补充铁也与较差的长期预后相关。本研究的目的是探讨补充组氨酸和肌肽如何减轻慢性肾脏病(CKD)贫血症状以及与铁过载状况相关的影响。用腺嘌呤诱导慢性肾脏病小鼠,通过灌胃给予组氨酸和肌肽,持续10天。此外,建立了小鼠铁过载模型,这些小鼠同时接受组氨酸和肌肽治疗。测量血红蛋白、非血红素铁、丙二醛(MDA)和铁参数。肌肽使促红细胞生成素(EPO)水平升高(35.62μg/ml±11.43),并使血红蛋白恢复(16.7g/dL±3.4)。当与组氨酸或肌肽一起补充铁时,对血红蛋白恢复(分别为14.22±1.7和13.82±2.15g/dL)、铁蛋白(59.5±16.4,52±29.5μg/ml)和非血红素铁(0.8±0.21,0.7±0.38nmol/mg)的影响比单独接受铁的组更好(p<0.05)。此外,在铁过载情况下,组氨酸和肌肽降低了非血红素铁和MDA(p<0.05)。在组氨酸和肌肽中观察到的这些积极作用可能与活性氧(ROS)清除有关。CKD模型中EPO恢复水平以及肌肽治疗中血红蛋白和铁蛋白的增加表明可能形成了铁-谷胱甘肽三元复合物。总之,我们的结果表明,在补充铁的情况下,组氨酸和肌肽对纠正血红蛋白以及预防铁过载状况具有有益作用。